Free Trial

Myriad Genetics (MYGN) SEC Filings & 10K Form

Myriad Genetics logo
$15.30 +0.30 (+2.00%)
(As of 11/20/2024 ET)

Recent Myriad Genetics SEC Filings

DateFilerForm TypeView
11/08/2024
7:18 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/11/2024
4:23 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
9:35 AM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:31 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:33 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:36 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
5:11 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:17 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:21 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
1:30 PM
Ancona Margaret (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:09 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
2:26 PM
Muzzey Dale (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
9:05 AM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
4:48 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
1:52 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
6:51 PM
Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:38 PM
Myriad Genetics (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:43 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
3:33 PM
Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
9:11 AM
Myriad Genetics (Subject)
Reitan Colleen F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:48 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:16 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:38 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
1:46 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
3:27 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
7:22 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/04/2024
4:57 PM
Myriad Genetics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
9:32 AM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:48 PM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
4:48 PM
Myriad Genetics (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:49 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:24 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
11:14 AM
Myriad Genetics (Subject)
Newcomer Lee Nisley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
7:14 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2024
3:31 PM
Myriad Genetics (Filer)
Form DEF 14A
04/17/2024
3:31 PM
Myriad Genetics (Filer)
Form DEFA14A
04/17/2024
3:33 PM
Myriad Genetics (Filer)
Form ARS
04/15/2024
3:25 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
04/08/2024
3:49 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:39 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Myriad Genetics (Subject)
Form SC 13G
03/04/2024
3:18 PM
Myriad Genetics (Issuer)
Solaiman Shereen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:31 AM
Myriad Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
7:24 AM
Camber Capital Management LP (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/29/2024
3:21 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2024
3:27 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
12:20 PM
Myriad Genetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
3:31 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/16/2024
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
4:52 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
7:30 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
5:34 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:41 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:19 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MYGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners